Ricklie Julian

Trials

Studies that name Ricklie Julian as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:47 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT06814496 · Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

  University of Arizona · recruiting · Melanoma, Medullary Thyroid Cancer, Sinonasal Undifferentiated Carcinoma · study chair
• Ph2
  NCT04169074 · Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)

  University of Arizona · terminated · HNSCC · principal investigator
• Ph2
  NCT03601507 · Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

  University of Arizona · terminated · CDKN2A-p16 Positive, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer Biology Program (CBP)
  P30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Koenraad Van Doorslaer · fiscal years 1999 to 2026
  Named on NCT03601507